Design and Characterization of Novel EphA2 Agonists for Targeted Delivery of Chemotherapy to Cancer Cells.
about
Necrosis-inducing peptide has the beneficial effect on killing tumor cells through neuropilin (NRP-1) targeting.Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine.The Sam-Sam interaction between Ship2 and the EphA2 receptor: design and analysis of peptide inhibitors.Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide-Drug Conjugate.Targeting Nanomedicines to Prostate Cancer: Evaluation of Specificity of Ligands to Two Different Receptors In Vivo.
P2860
Design and Characterization of Novel EphA2 Agonists for Targeted Delivery of Chemotherapy to Cancer Cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Design and Characterization of ...... Chemotherapy to Cancer Cells.
@ast
Design and Characterization of ...... Chemotherapy to Cancer Cells.
@en
type
label
Design and Characterization of ...... Chemotherapy to Cancer Cells.
@ast
Design and Characterization of ...... Chemotherapy to Cancer Cells.
@en
prefLabel
Design and Characterization of ...... Chemotherapy to Cancer Cells.
@ast
Design and Characterization of ...... Chemotherapy to Cancer Cells.
@en
P2093
P2860
P1476
Design and Characterization of ...... Chemotherapy to Cancer Cells.
@en
P2093
Angela Purves
Bridget A Quinn
Elisa Barile
Irina Zharkikh
John L Stebbins
Maurizio Pellecchia
Paul B Fisher
Robert G Oshima
P2860
P304
P356
10.1016/J.CHEMBIOL.2015.06.011
P577
2015-07-09T00:00:00Z